Compare CERT & ATEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CERT | ATEC |
|---|---|---|
| Founded | 2008 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.3B |
| IPO Year | 2020 | 2006 |
| Metric | CERT | ATEC |
|---|---|---|
| Price | $7.75 | $10.39 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 11 |
| Target Price | $11.67 | ★ $22.00 |
| AVG Volume (30 Days) | ★ 3.7M | 2.1M |
| Earning Date | 05-11-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 87.50 | 15.04 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $418,838,000.00 | $101,739,000.00 |
| Revenue This Year | $4.18 | $18.97 |
| Revenue Next Year | $5.39 | $16.70 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 8.75 | N/A |
| 52 Week Low | $4.45 | $6.82 |
| 52 Week High | $13.88 | $23.29 |
| Indicator | CERT | ATEC |
|---|---|---|
| Relative Strength Index (RSI) | 45.77 | 64.27 |
| Support Level | $6.57 | $8.06 |
| Resistance Level | $7.44 | $13.08 |
| Average True Range (ATR) | 0.37 | 0.36 |
| MACD | -0.03 | 0.15 |
| Stochastic Oscillator | 22.86 | 89.96 |
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval, and increase patient access to medicines. The company has its business presence in the Americas, which is also its key revenue-generating market, EMEA, and the Asia Pacific region.
Alphatec Holdings Inc is a medical technology company focused on the designing, development, and advancement of products for the surgical treatment of spinal disorders associated with disease and degeneration, congenital deformities, and trauma. The company's spine approach technologies include Posterior Cervical Fusion, Anterior Cervical Discectomy and Fusion, Lateral Interbody Fusion, and Posterior Lumbar Interbody Fusion among others. Its procedural offerings are designed to address the underlying causes of spinal pathology by advancing the three fundamental objectives of spine surgery: (1) decompression of neural elements, (2) stabilization of spinal segments, and (3) restoration and maintenance of proper spinal alignment.